Robbins Farley’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Robbins Farley's PFE Position: Q2 2026 in Review
Robbins Farley reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $4.39K and leaving 1,127 shares worth $27.1K. The position accounts for 0.01% of the portfolio, ranked #100.
Robbins Farley first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.51M in Q4 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Robbins Farley held 1,127 shares of Pfizer worth $27.1K as of Q2 2026.
- Robbins Farley sold 168 Pfizer shares in Q2 2026, an estimated $4.39K.
- Pfizer made up 0.01% of Robbins Farley's portfolio in Q2 2026, its #100 holding.
- Robbins Farley first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
- Robbins Farley's Pfizer position peaked at $4.51M in Q4 2020.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.